Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InfuSystem Holdings, IncINFU · Entity 6163 | Director · President and CEO | March 16, 2017 | March 22, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InfuSystem Holdings, Inc
Report date March 16, 2017 · Filed March 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.15 · Expires 2027-03-16 | Direct | 30,000 |
Reported balance
After 2017-03-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-03-16 · Grant · Acquired 30,000 · Balance 30,000 F1: The option, representing the right to purchase a total of 30,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The option, representing the right to purchase a total of 30,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2017 Filed Mar 22, 2017 18:59 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001014108-17-000069 · primary_doc.xml · derivative · entry 1 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-03-16 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 30,000 shares of InfuSystem Holdings, Inc. common stock, vests in 36-monthly installments beginning April 16, 2017. Read SEC document |
| December 19, 2016 Filed Dec 19, 2016 21:37 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $2.35 | $11,750.00 |
DisclosureSEC source: 0001014108-16-000547 · primary_doc.xml · nonDerivative · entry 3 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,296 Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:37 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,000 | $2.34 | $4,687.40 |
DisclosureSEC source: 0001014108-16-000547 · primary_doc.xml · nonDerivative · entry 2 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,296 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:37 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $2.30 | $11,500.00 |
DisclosureSEC source: 0001014108-16-000547 · primary_doc.xml · nonDerivative · entry 1 Steen Eric K · CIK 0001572871 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,296 F1 · balance_after: This total has been adjusted to reflect the current holdings since the last filing of a beneficial ownership report by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.